People / SEC CIK 0001855684
Ajim Tamboli
Career history and related SEC filings
Career history
-
Chief Financial Officer
Board appointment Apr 17, 2026. Effective Apr 20, 2026.
-
–
ADARx Pharmaceuticals
Chief Financial Officer
-
–
Arbor Biotechnologies
Chief Financial Officer
-
–
-
–
Rodin Therapeutics
Chief Financial Officer
Related filing events
Browse linked events from SEC filings within FilingRelay's coverage.
12 events
Form 4Insider transactions
- Shares
-
42,500
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
13,600
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
5,000
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
41,234
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
41,233
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
41,233
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
45,700
- Price per share
-
0.00
8-KLeadership changes
Form 4Insider transactions
- Shares
-
129,850
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
111,700
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
56,649
- Price per share
-
0.00
Form 4Insider transactions
- Shares
-
100,938
- Price per share
-
0.00